Chapter title |
A Zinc Sulphate-Resistant Acrodermatitis Enteropathica Patient with a Novel Mutation in SLC39A4 Gene.
|
---|---|
Chapter number | 38 |
Book title |
JIMD Reports - Case and Research Reports, 2011/2
|
Published in |
JIMD Reports, September 2011
|
DOI | 10.1007/8904_2011_38 |
Pubmed ID | |
Book ISBNs |
978-3-64-224757-6, 978-3-64-224758-3
|
Authors |
Kilic M, Taskesen M, Coskun T, Gürakan F, Tokatli A, Sivri HS, Dursun A, Schmitt S, Küry S, M. Kilic, M. Taskesen, T. Coskun, F. Gürakan, A. Tokatli, H. S. Sivri, A. Dursun, S. Schmitt, S. Küry, Kilic, M., Taskesen, M., Coskun, T., Gürakan, F., Tokatli, A., Sivri, H. S., Dursun, A., Schmitt, S., Küry, S. |
Abstract |
Acrodermatitis enteropathica (AE) is a rare autosomal recessive disorder of zinc deficiency due to an abnormal intestinal zinc transporter. It is characterized by the triad of acral dermatitis, alopecia, and diarrhoea. Once AE is correctly diagnosed, patients are treated with orally administered zinc sulphate. In some patients, relapses occur during adolescence, despite the regular treatment. Here, we discuss the clinical and molecular features of a 13-year-old adolescent girl with acrodermatitis enteropathica who was resistant to high-dose zinc sulphate therapy. We successfully treated the patient with zinc gluconate and vitamin C, and we detected a novel homozygous c.541_551dup (p.Leu186fsX38) mutation in the exon 3 of her SLC39A4 gene. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 15 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Postgraduate | 3 | 20% |
Other | 2 | 13% |
Student > Ph. D. Student | 2 | 13% |
Researcher | 2 | 13% |
Student > Doctoral Student | 1 | 7% |
Other | 1 | 7% |
Unknown | 4 | 27% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 5 | 33% |
Agricultural and Biological Sciences | 2 | 13% |
Business, Management and Accounting | 1 | 7% |
Social Sciences | 1 | 7% |
Neuroscience | 1 | 7% |
Other | 0 | 0% |
Unknown | 5 | 33% |